1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Bangladesh Pharmaceuticals and Healthcare Report Q4 2015

Bangladesh Pharmaceuticals and Healthcare Report Q4 2015

  • September 2015
  • -
  • Business Monitor International
  • -
  • 100 pages

Includes 3 FREE quarterly updates

BMI View: Private consumption growth in Bangladesh will continue to gather momentum, contributing tothe pharmaceutical and healthcare sector expansion. In addition, the recent increase in the governmentbudget for health will translate in improved access to healthcare services, including in rural areas,prioritizing investments in infrastructure and telemedicine. While the sector will present substantial growthpotential over the next decade given rising incomes and higher levels of urbanisation, low per capitaspending on medicines will ensure that generic medicines continue to account for the largest market share,albeit this figure is expected to gradually moderate due to improving access to innovative pharmaceuticals.Risk/Reward Index:

In Q415 Bangladesh RRI score remains stable at 41.8 (out of 100). Bangladesh alsoretains its ranking position in our RRI matrix, standing as the 15th most attractive market to pharmaceuticalinvestors out of 19 markets in the Asia Pacific region. Bangladesh's score is driven by a largepharmaceutical market (market expenditure score of 10.0 out of 20) and rapid drug market expansion(sector value growth score of 8.4 out of 12), but dragged down by low levels of drug spending per capita(spending per capita score of 1.2 out of 12) and limited intellectual property protection (patent respect scoreof 1.4 out of 7).

Table Of Contents

Bangladesh Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Bangladesh 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2011-2019) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2011-2019) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Bangladesh 2011-2019) 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Bangladesh 2011-2019) 26
OTC Medicine Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Bangladesh 2011-2019) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Bangladesh 2013-2019) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Bangladesh 2013-2019) 31
Key Risks To BMI's Forecast Scenario 31
Macroeconomic Forecasts 32
Economic Analysis 32
Industry Risk Reward Ratings 37
Asia Pacific Risk/Reward Index 37
Bangladesh Risk/Reward Index 43
Rewards 43
Risks 43
Market Overview 45
Industry Trends And Developments 46
Epidemiology 46
Healthcare Sector 47
Healthcare Sector Financing and Budget Priority Areas (FY2015/2016) 52
Healthcare Infrastructure 54
Table: Healthcare Resources (Bangladesh 2009-2014) 54
Table: Healthcare Personnel (Bangladesh 2009-2014) 54
Table: Healthcare Activity (Bangladesh 2009-2014) 55
Research And Development 56
Table: Suggestions Made By University Of Dhaka's Faculty Of Pharmacy To Improve Pharmaceutical Research 57
Clinical Trials 58
Regulatory Development 60
Table: Steps To Establish A Pharmaceutical Manufacturing Unit And Obtain A Drug Manufacturing Licence 62
Intellectual Property Issues 62
Pricing And Reimbursement 64
Competitive Landscape 67
Pharmaceutical Industry 67
Company Developments 69
Pharmaceutical Distribution 70
Company Profile 71
Beximco Pharmaceuticals 71
Eskayef 74
Novartis 77
Renata 79
Sanofi 83
Square Pharmaceuticals 86
Demographic Forecast 89
Table: Population Headline Indicators (Bangladesh 1990-2025) 90
Table: Key Population Ratios (Bangladesh 1990-2025) 90
Table: Urban/Rural Population and Life Expectancy (Bangladesh 1990-2025) 91
Table: Population By Age Group (Bangladesh 1990-2025) 91
Table: Population By Age Group % (Bangladesh 1990-2025) 92
Glossary 94
Methodology 96
Pharmaceutical Expenditure Forecast Model 96
Healthcare Expenditure Forecast Model 96
Notes On Methodology 97
Risk/Reward Index Methodology 98
Index Overview 99
Table: Pharmaceutical Risk/Reward Index Indicators 99
Indicator Weightings 100

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Download Unlimited Documents from Trusted Public Sources

Generic Drug Industry in the US

  • September 2016
    9 pages
  • Generic Drug  

  • United States  

View report >

Opioid and Therapy Market in the US

  • September 2016
    11 pages
  • Opioid  

    Therapy  

    Analgesic  

  • United States  

View report >

Opioid Market in the US

  • September 2016
    13 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • United States  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.